KEVIN NAZEMI

Kevin Nazemi stands out as a prominent investor and entrepreneur in the dynamic fields of healthcare and life sciences. As a Partner at Andreessen Horowitz (a16z) within their dedicated Bio + Health fund, he plays a pivotal role in identifying and nurturing innovative companies poised to reshape the future of health. His investment focus at a16z spans a broad spectrum, including digital health solutions, cutting-edge biotechnology, advanced health technology, and the application of artificial intelligence in healthcare, all aimed at improving patient outcomes and healthcare delivery.

Nazemi's career background is marked by significant entrepreneurial success, providing him with invaluable insights as a venture capitalist. He is widely recognized as a co-founder of Oscar Health, a technology-driven health insurance company that aimed to simplify healthcare access and experience through user-friendly interfaces and integrated care. His vision helped Oscar Health grow into a notable player in the health insurance market, demonstrating his ability to build and scale impactful healthcare ventures. Following his work at Oscar, Nazemi co-founded Honest Medical Group, another innovative company focused on transforming how healthcare is delivered, further solidifying his reputation as a leader in healthcare innovation.

His unique blend of medical, business, and technological expertise is underpinned by a robust educational foundation. Kevin Nazemi holds an MD from Harvard Medical School, an MBA from Harvard Business School, and a BS from Stanford University. This multidisciplinary background equips him with a deep understanding of both the clinical complexities and the business opportunities within the healthcare sector, allowing him to make informed investment decisions and provide strategic guidance to portfolio companies.

At a16z Bio + Health, Kevin Nazemi leverages his extensive experience as an operator to support founders who are tackling some of the most pressing challenges in healthcare. He is passionate about backing companies that are developing novel therapies, creating more efficient care models, and utilizing technology to make healthcare more accessible and affordable. His work as an investor at Andreessen Horowitz continues to drive innovation, fostering the next generation of healthcare leaders and solutions that promise to make a lasting positive impact on global health.